Atrial fibrillation: diagnosis and management

higher than 5 or 1 INR value higher than 8 within the past 6 months • 2 INR values less than 1.5 within the past 6 months • TTR less than 65%. [2014] 1.6.12 When reassessing anticoagulation, take into account and if possible address the following factors that may contribute to poor anticoagulation control: • cognitive function • adherence to prescribed therapy • illness • interacting drug therapy • lifestyle factors including diet and alcohol consumption. [2014] 1.6.13 If poor anticoagulation control cannot be improved, evaluate the risks and benefits of alternative stroke prevention strategies and discuss these with the person. [2014] Self-monitoring and self-management of vitamin K antagonists NICE has developed diagnostics guidance on atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system). Antiplatelets For guidance on antiplatelet therapy for people who have had a myocardial infarction and are having anticoagulation, see antiplatelet therapy for people with an ongoing separate indication for anticoagulation in NICE's guideline on acute coronary syndromes. 1.6.14 Do not offer aspirin monotherapy solely for stroke prevention to people with atrial fibrillation. [2014] Review of people with atrial fibrillation 1.6.15 For people who are not taking an anticoagulant, review
